1-5 of 5
Changgui Li
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Targeting CD40 enhances antibody- and CD8-mediated protection against respiratory syncytial virus infection

Free
Abenaya Muralidharan, Marsha Russell, Louise Larocque, Caroline Gravel, Changgui Li, Wangxue Chen, Terry Cyr, Jessie R Lavoie, Aaron Farnsworth, Michael Rosu-Myles, Lisheng Wang, Xuguang Li
Journal: The Journal of Immunology
J Immunol (2019) 202 (1_Supplement): 139.13.
https://doi.org/10.4049/jimmunol.202.Supp.139.13
Published: 01 May 2019
View articletitled, Targeting CD40 enhances antibody- and CD8-mediated protection against respiratory syncytial virus infection
Add to Citation Manager for Targeting CD40 enhances antibody- and CD8-mediated protection against respiratory syncytial virus infection
Journal Articles

A Recombinant G Protein Plus Cyclosporine A–Based Respiratory Syncytial Virus Vaccine Elicits Humoral and Regulatory T Cell Responses against Infection without Vaccine-Enhanced Disease

Free
Chaofan Li, Xian Zhou, Yiwei Zhong, Changgui Li, Aihua Dong, Zhonghuai He, Shuren Zhang, Bin Wang
Journal: The Journal of Immunology
J Immunol (2016) 196 (4): 1721–1731.
https://doi.org/10.4049/jimmunol.1502103
Published: 15 February 2016
View articletitled, A Recombinant G Protein Plus Cyclosporine A–Based Respiratory Syncytial Virus Vaccine Elicits Humoral and Regulatory T Cell Responses against Infection without Vaccine-Enhanced Disease
Open the PDF for A Recombinant G Protein Plus Cyclosporine A–Based Respiratory Syncytial Virus Vaccine Elicits Humoral and Regulatory T Cell Responses against Infection without Vaccine-Enhanced Disease in another window
Add to Citation Manager for A Recombinant G Protein Plus Cyclosporine A–Based Respiratory Syncytial Virus Vaccine Elicits Humoral and Regulatory T Cell Responses against Infection without Vaccine-Enhanced Disease
Includes: Supplementary data
Journal Articles

A broadly protective anti-influenza neuraminidase monoclonal antibody (VAC11P.1100)

Free
Anwar Hashem, Tracey Doyle, Changgui Li, Gary Van Domselaar, Junzhi Wang, Aeron Hurt, Earl Brown, Xuguang Li
Journal: The Journal of Immunology
J Immunol (2015) 194 (1_Supplement): 212.8.
https://doi.org/10.4049/jimmunol.194.Supp.212.8
Published: 01 May 2015
View articletitled, A broadly protective anti-influenza neuraminidase monoclonal antibody (VAC11P.1100)
Add to Citation Manager for A broadly protective anti-influenza neuraminidase monoclonal antibody (VAC11P.1100)
Journal Articles

CD40 Ligand Preferentially Modulates Immune Response and Enhances Protection against Influenza Virus

Free
Anwar M. Hashem, Caroline Gravel, Ze Chen, Yinglei Yi, Monika Tocchi, Bozena Jaentschke, Xingliang Fan, Changgui Li, Michael Rosu-Myles, Alexander Pereboev, Runtao He, Junzhi Wang, Xuguang Li
Journal: The Journal of Immunology
J Immunol (2014) 193 (2): 722–734.
https://doi.org/10.4049/jimmunol.1300093
Published: 15 July 2014
View articletitled, CD40 Ligand Preferentially Modulates Immune Response and Enhances Protection against Influenza Virus
Open the PDF for CD40 Ligand Preferentially Modulates Immune Response and Enhances Protection against Influenza Virus in another window
Add to Citation Manager for CD40 Ligand Preferentially Modulates Immune Response and Enhances Protection against Influenza Virus
Includes: Supplementary data
Journal Articles

CD40-targeted nucleoprotein provides enhanced immune response and protection against influenza virus (VAC2P.927)

Free
Anwar Hashem, Caroline Gravel, Monika Tocchi, Bozena Jaentschke, Xingliang Fan, Ze Chen, Changgui Li, Wang Junzhi, Xuguang Li
Journal: The Journal of Immunology
J Immunol (2014) 192 (1_Supplement): 72.5.
https://doi.org/10.4049/jimmunol.192.Supp.72.5
Published: 01 May 2014
View articletitled, CD40-targeted nucleoprotein provides enhanced immune response and protection against influenza virus (VAC2P.927)
Add to Citation Manager for CD40-targeted nucleoprotein provides enhanced immune response and protection against influenza virus (VAC2P.927)